MeritValue

Nextel Medical Corp.

MAJIdata completeness 75%6 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'depreciationAmortization'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2011FY 2012FY 2018FY 2019FY 2020
Revenue$01$01$02$03$03
Net income−$100,6144−$6.07M4−$5755−$125,1646−$435,9506
Operating cash flow−$64,2467−$215,4277−$8848−$9,2979−$169,7319
Capital expenditure—————
Free cash flow (derived)—————
Total debt—————
Cash & equivalents$71,16010$5,86510$1,58911$011$011
Diluted shares97.5M48.8M249.8M249.8M249.8M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.02
your share of equity
Profit it earned you last year
−$0.02
Free cash flow it threw off
—
Debt you’d be carrying
—

10 shares is a claim on −$0.02 of net worth that earned you −$0.02 last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+156% shares · 5y

Share count is up 156% over 5 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2011-04-30 · accession 0001185185-12-001649 (SalesRevenueNet)
  2. 10-K · period ending 2018-04-30 · accession 0001079973-19-000471 (Revenues)
  3. 10-K · period ending 2019-04-30 · accession 0001079973-20-000675 (Revenues)
  4. 10-K · period ending 2011-04-30 · accession 0001185185-12-001649 (NetIncomeLoss)
  5. 10-K · period ending 2018-04-30 · accession 0001079973-19-000471 (NetIncomeLoss)
  6. 10-K · period ending 2019-04-30 · accession 0001079973-20-000675 (NetIncomeLoss)
  7. 10-K · period ending 2011-04-30 · accession 0001185185-12-001649 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2018-04-30 · accession 0001079973-19-000471 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2019-04-30 · accession 0001079973-20-000675 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2011-04-30 · accession 0001185185-12-001649 (CashAndCashEquivalentsAtCarryingValue)
  11. 10-K · period ending 2018-04-30 · accession 0001079973-20-000675 (CashAndCashEquivalentsAtCarryingValue)